Select Medical (SEM) is scheduled to release its fourth-quarter 2025 earnings on Thursday, February 19th. Analysts anticipate the company will report earnings of $0.23 per share and revenues reaching $1.364 billion for the period. The company currently holds a 'Moderate Buy' consensus rating from analysts, with a target price of $17.80. Notably, institutional investors maintain a significant stake, owning approximately 89.48% of the company's stock. This upcoming report will be crucial for investors to assess SEM's financial health against market expectations.
Get AI-powered deep analysis for every story with a paid subscription
Upgrade for Analysis